Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Biofourmis Everion+ (G2)

K-Number: K233418 · 2024-05-09

Decision Date2024-05-09
Product CodeMSX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Biofourmis Everion+ (G2) is the device name listed in this FDA 510(k) record. The listed applicant is Biofourmis Singapore Pte., Ltd.. It received FDA 510(k) clearance on 2024-05-09 under 510(k) number K233418. The device is classified under product code MSX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Biofourmis Everion+ (G2)?

Biofourmis Everion+ (G2) is a medical device that received FDA 510(k) clearance on 2024-05-09. The listed applicant is Biofourmis Singapore Pte., Ltd.. The 510(k) number is K233418.

When did Biofourmis Everion+ (G2) receive FDA 510(k) clearance?

Biofourmis Everion+ (G2) received FDA 510(k) clearance on 2024-05-09, under 510(k) number K233418.

Who is the listed applicant for Biofourmis Everion+ (G2)?

The FDA 510(k) record lists Biofourmis Singapore Pte., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Biofourmis Everion+ (G2)?

The FDA product code for Biofourmis Everion+ (G2) is MSX.

Other records listing Biofourmis Singapore Pte., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: MSX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.